Related Experiment Video
Updated: May 11, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
Published on: October 29, 2015
Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges
Maud Lemoine1, Shevanthi Nayagam, Mark Thursz
1Medical Research Council, The Gambia Unit, Disease Control & Elimination theme, Liver Unit, Atlantic Road, Fajara, PO Box 273 Banjul, The Gambia.
Abstract:
Chronic viral hepatitis is a major public health issue worldwide and mostly affects resource-limited countries. These regions combine a considerable set of barriers to containing the epidemic, including shortage of healthcare workers, poor medical infrastructures, insufficient screening and poor access to care and treatment. At a time when morbidity and mortality of chronic liver disease has been widely improved in wealthy countries by new innovative strategies and potent antiviral drugs, it is now urgent to face the challenges of better management of chronic hepatitis in resource-poor countries from the perspectives of global health and social justice.
Related Concept Videos
Viral Hepatitis I: Introduction
Hepatitis
Inhibitors of Viral Protein Synthesis
Retrovirus Life Cycles
Microorganisms in Medicine and Therapeutics
Human Virome

